Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 HKD | -0.35% | +1.43% | -18.16% |
01:00am | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
Jun. 05 | Sino Biopharmaceutical Presents Findings of Anti-Tumor Drug at American Cancer Conference | MT |
Sales 2024 * | 29.1B 4.02B 31.37B | Sales 2025 * | 32.3B 4.46B 34.83B | Capitalization | 48.49B 6.69B 52.28B |
---|---|---|---|---|---|
Net income 2024 * | 2.73B 376M 2.94B | Net income 2025 * | 3.11B 429M 3.35B | EV / Sales 2024 * | 1.52 x |
Net cash position 2024 * | 4.36B 603M 4.71B | Net cash position 2025 * | 7.41B 1.02B 7.99B | EV / Sales 2025 * | 1.27 x |
P/E ratio 2024 * |
17.9
x | P/E ratio 2025 * |
15.7
x | Employees | 25,806 |
Yield 2024 * |
2.05% | Yield 2025 * |
2.39% | Free-Float | 50.56% |
1 day | -0.35% | ||
1 week | +1.43% | ||
1 month | -1.73% | ||
3 months | -3.40% | ||
6 months | -17.68% | ||
Current year | -18.16% |
Managers | Title | Age | Since |
---|---|---|---|
S Y Tse
CEO | Chief Executive Officer | 29 | 19-10-22 |
Ping Tse
FOU | Founder | 72 | 00-02-01 |
Chun Ling Li
DFI | Director of Finance/CFO | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ping Tse
FOU | Founder | 72 | 00-02-01 |
Director/Board Member | 60 | 04-12-31 | |
Hsin Tse
BRD | Director/Board Member | 54 | 95-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.40% | 2 M€ | -16.85% | - | |
2.02% | 4 M€ | -27.92% | ||
0.82% | 3 M€ | +2.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-06 | 2.84 | -0.35% | 24 613 683 |
24-06-05 | 2.85 | +0.35% | 35,360,690 |
24-06-04 | 2.84 | +1.79% | 39,323,790 |
24-06-03 | 2.79 | -1.76% | 51,424,320 |
24-05-31 | 2.84 | +1.43% | 134,336,900 |
Delayed Quote Hong Kong S.E., June 06, 2024 at 04:08 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.16% | 6.69B | |
+42.69% | 749B | |
+38.76% | 605B | |
-6.87% | 351B | |
+18.74% | 328B | |
+6.76% | 292B | |
+18.91% | 248B | |
-2.25% | 214B | |
+11.30% | 216B | |
+2.64% | 167B |
- Stock Market
- Equities
- 1177 Stock